Kenya's Ministry of Health has announced a temporary global disruption in the supply of the Rotavac frozen rotavirus vaccine due to production delays. This shortage is expected to impact vaccine distribution across the country during the 2026-2027 period.

• Available stock of the rotavirus vaccine in Kenya is estimated to last less than one month as of March 3, 2026.
• Key parties involved include Health Cabinet Secretary Aden Duale, Gavi, the Vaccine Alliance, and the vaccine manufacturer Bharat Biotech.
• Despite the shortage, parents are urged to continue with routine immunisation visits and strengthen home-based diarrhoea prevention methods, while the ministry works with partners like UNICEF to expedite shipments and ensure equitable distribution.